Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
Triple Negative Breast Cancer Pathophysiology | Oncology Nurses Quality Improvement Series
Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer | Scientific Reports
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies - ESMO Open
Current Oncology | Free Full-Text | Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer | HTML
Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer | PLOS ONE
Breast cancer-specific mortality in early breast cancer as defined by high-risk clinical and pathologic characteristics | PLOS ONE
Triple-negative breast cancer molecular subtyping and treatment progress
Triple‑negative breast cancer: A run‑through of features, classification and current therapies (Review)
Integrating Immunotherapy Into the Treatment Landscape for Patients With Triple-Negative Breast Cancer | American Society of Clinical Oncology Educational Book
Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer | Journal of Nanobiotechnology | Full Text
Different Pattern of Recurrence for Triple-negative Breast Cancer - CancerConnect
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence | Scientific Reports
Triple-negative breast cancer: treatment challenges and solutions | BCTT
![PDF] Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/623d56600e2bac528db05270048e03c7a6107aae/4-Figure2-1.png "PDF] Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence | Semantic Scholar")
PDF] Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence | Semantic Scholar
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial ...
Current Treatment Landscape and Emerging Therapies for Metastatic Triple-Negative Breast Cancer
Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) network - The Breast
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect
Risk of recurrence in different sites in triple-negative breast cancer... | Download Scientific Diagram
Sonography with vertical orientation feature predicts worse disease outcome in triple negative breast cancer - The Breast
Cureus | Advancements in the Treatment of Triple-Negative Breast Cancer: A Narrative Review of the Literature
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients | British Journal of Cancer
